GrowthWorks

HIGHLINE is a Pre-Seed investor & Acceleration Platform that helps digital startups get follow-on capital, backed by leading VCs with offices in Vancouver & Toronto. We believe in providing our founders with far more than capital. Yet unlike most accelerators, we have no rigid start/end dates throughout the year. By joining the HIGHLINE family, you get to call on us for advice on an ongoing basis, gain access to our premium network and monthly founder events. We’ll do our best to help with fundraising challenges and partner with incubators to help deliver specialized programming. [Growlab Ventures](https://www.crunchbase.com/organization/growlab-ventures) and [Extreme Startups](https://www.crunchbase.com/organization/extreme-startups) have merged to create HIGHLINEvc as of August 2014.

BuildDirect Technologies Inc. operates an online marketplace that connects homeowners and home improvement professionals in North America with global suppliers of building materials. Founded in 1999 and based in Vancouver, Canada, the company offers a wide range of products, including flooring, decking, tiles, and other building materials. Its platform facilitates the buying and selling of these materials, enhancing accessibility for consumers and professionals alike. BuildDirect's services also include BuildDirect Gateway, a global supply chain platform that provides third parties with access to advanced warehousing and logistics solutions, streamlining the shipping process from manufacturing to last-mile delivery. The company generates the majority of its revenue from its primary platform in the United States.

General Fusion Inc. is a Canadian company focused on the development of commercial Magnetized Target Fusion (MTF), a promising hybrid approach that combines elements of magnetic fusion and inertial confinement fusion. Founded in 2002 and based in Burnaby, the company aims to create utility-scale fusion power plants that can provide clean, safe, and abundant energy. General Fusion is pioneering a patent-pending concept that leverages advancements in MTF, which has seen limited exploration since the 1970s. The company is dedicated to demonstrating and commercializing this innovative energy solution by the end of the decade. It is supported by a network of global energy venture capital firms, industry leaders, and technology innovators, all working to reduce technical risks and accelerate the path to viable fusion energy.

Vitrium Systems Inc. specializes in document security and digital rights management (DRM) software tailored for various file formats, including PDF, office documents, and images. Founded in 2005 and based in Vancouver, Canada, the company provides solutions that allow content creators, publishers, and distributors to safeguard proprietary and confidential materials. Vitrium's offerings encompass document security, secure file sharing, image protection, and analytics, as well as consulting and support services. Its technology integrates seamlessly with existing enterprise systems, enabling organizations to implement military-grade encryption and file-level protection. This facilitates the secure distribution of documents and images through various channels, including websites and email, while providing insights into user engagement through tracking and auditing capabilities. Vitrium serves a diverse range of industries, including education, finance, media, and technology, and has reached a global audience of over a million users.

Mixpo, Inc. operates a comprehensive advertising platform that supports advertisers, agencies, and media companies in creating, delivering, and measuring digital advertising campaigns. Founded in 2002 and based in Seattle, Washington, with additional offices in Victoria, Canada, and Portland, Oregon, Mixpo enhances the effectiveness of advertising through its solutions that connect various channels and optimize campaign performance. The platform offers capabilities for measurement, bid optimization, targeting, and retargeting, while providing valuable data insights, including ad verification and performance metrics segmented by demographics and device types. Mixpo's services cater to a wide array of clients, including brand advertisers, local and national media sales, and advertising networks. As of 2017, Mixpo operates as a subsidiary of Netsertive, Inc.

Layer 7 Technologies provides security and management products for API-driven integrations spanning the extended hybrid enterprise. It offers API management solutions such as API Proxy, a virtual API gateway that gives API publishers a tool for securing, orchestrating, and optimizing APIs as well as enforcing SLAs; XML Firewall that is designed to address access, federation, and message security needs in service oriented architecture (SOA) based integrations; SOA Gateway, an API Gateway that provides data translation, contextual routing, SLA management, caching, protocol switching, and B2B functionality; and Mobile Access Gateway, which simplifies the process of adapting internal data, application, and security infrastructure for mobile use. The company also offers developer management solutions, including API Portal, a platform for developer onboarding, engagement, and management; and operations management solutions such as API Service Manager that simplifies API, service, and gateway management across datacenters and the cloud. In addition, it offers identity management solutions, including OAuth Toolkit which empowers users to control access to their APIs; and Security Token Service for API identity translation and federation. Further, the company offers API academy training in the areas of introduction, API design and architecture, API strategy consulting, and hackathon management; IT services, such as architectural consulting, implementation, and operational health check; and gateway, API portal, and administrator training services. The company was founded in 2003 and is based in Vancouver, Canada. Currently, it operates as a subsidiary of CA Technologies.

Bootup Labs was a startup accelerator in Vancouver, BC that helped 8 companies go "from zero to fundable." Bootup Labs recruited promising entrepreneurs and provides mentorship, ongoing support, investment and office space to help define their business and secure venture financing.

Neuromed Pharmaceuticals is focused on the development, production, and marketing of pain therapies in Canada and the United States. Neuromed Pharmaceuticals was acquired by Zalicus in December 2009. Neuromed Pharmaceuticals was founded in 1998 and is based in Vancouver, Canada.

Protiva Biotherapeutics, Inc. is a biotechnology company specializing in the development of nucleic acid-based pharmaceutical products aimed at combating a range of human diseases, including cancer, influenza, Ebola, inflammatory conditions, and chronic viral infections. The company’s product portfolio features Pro 1, a tumor cell growth inhibitor, and Pro-101, an siRNA product designed to impede the production of a protein associated with tumor growth. Additionally, Protiva develops Pro-B, which inhibits the expression of apolipoprotein B, as well as Pro-EBOV and Pro-MARV, targeting the replication of the Ebola and Marburg viruses. The company employs Stable Nucleic-Acid Lipid Particle technology for effective delivery of nucleic acid therapies, including short interfering RNA (siRNA). Protiva is also engaged in developing siRNA products for the treatment of hepatitis B and C. Founded in 2000, Protiva Biotherapeutics operates a research and development facility in Vancouver, Canada, and is based in Seattle, Washington. As of 2008, it functions as a subsidiary of Tekmira Pharmaceuticals Corp.

Layer 7 Technologies provides security and management products for API-driven integrations spanning the extended hybrid enterprise. It offers API management solutions such as API Proxy, a virtual API gateway that gives API publishers a tool for securing, orchestrating, and optimizing APIs as well as enforcing SLAs; XML Firewall that is designed to address access, federation, and message security needs in service oriented architecture (SOA) based integrations; SOA Gateway, an API Gateway that provides data translation, contextual routing, SLA management, caching, protocol switching, and B2B functionality; and Mobile Access Gateway, which simplifies the process of adapting internal data, application, and security infrastructure for mobile use. The company also offers developer management solutions, including API Portal, a platform for developer onboarding, engagement, and management; and operations management solutions such as API Service Manager that simplifies API, service, and gateway management across datacenters and the cloud. In addition, it offers identity management solutions, including OAuth Toolkit which empowers users to control access to their APIs; and Security Token Service for API identity translation and federation. Further, the company offers API academy training in the areas of introduction, API design and architecture, API strategy consulting, and hackathon management; IT services, such as architectural consulting, implementation, and operational health check; and gateway, API portal, and administrator training services. The company was founded in 2003 and is based in Vancouver, Canada. Currently, it operates as a subsidiary of CA Technologies.

Protiva Biotherapeutics, Inc. is a biotechnology company specializing in the development of nucleic acid-based pharmaceutical products aimed at combating a range of human diseases, including cancer, influenza, Ebola, inflammatory conditions, and chronic viral infections. The company’s product portfolio features Pro 1, a tumor cell growth inhibitor, and Pro-101, an siRNA product designed to impede the production of a protein associated with tumor growth. Additionally, Protiva develops Pro-B, which inhibits the expression of apolipoprotein B, as well as Pro-EBOV and Pro-MARV, targeting the replication of the Ebola and Marburg viruses. The company employs Stable Nucleic-Acid Lipid Particle technology for effective delivery of nucleic acid therapies, including short interfering RNA (siRNA). Protiva is also engaged in developing siRNA products for the treatment of hepatitis B and C. Founded in 2000, Protiva Biotherapeutics operates a research and development facility in Vancouver, Canada, and is based in Seattle, Washington. As of 2008, it functions as a subsidiary of Tekmira Pharmaceuticals Corp.

Neuromed Pharmaceuticals is focused on the development, production, and marketing of pain therapies in Canada and the United States. Neuromed Pharmaceuticals was acquired by Zalicus in December 2009. Neuromed Pharmaceuticals was founded in 1998 and is based in Vancouver, Canada.

QuIC Financial Technologies, Inc. specializes in developing simulation, risk calculation, and pricing platform solutions tailored for financial institutions and companies. The firm's QuIC product suite features an n-dimensional vector-based calculator designed to solve complex mathematical problems. Key products include the QuIC Engine, which delivers supercomputer-level performance on desktop computers, and QuIC Script, a vector computing language for formulating financial solutions. QuIC Analytics offers a range of instruments covering interest rate and foreign exchange derivatives, equities, commodities, hybrids, asset-backed securities, and credit derivatives, along with various utility function libraries. Additionally, QuIC provides the QuIC Workbench for developing and visualizing QuIC Script, as well as the QuIC Simulation Framework for enterprise-scale portfolio simulation. Integration products such as QuIC Dispatch and QuIC Bridge facilitate seamless connections with client solutions and existing models. The company also offers support services, system integration, custom development, and training resources. Headquartered in Vancouver, Canada, QuIC Financial Technologies operates additional offices in London and New York.

Mixpo, Inc. operates a comprehensive advertising platform that supports advertisers, agencies, and media companies in creating, delivering, and measuring digital advertising campaigns. Founded in 2002 and based in Seattle, Washington, with additional offices in Victoria, Canada, and Portland, Oregon, Mixpo enhances the effectiveness of advertising through its solutions that connect various channels and optimize campaign performance. The platform offers capabilities for measurement, bid optimization, targeting, and retargeting, while providing valuable data insights, including ad verification and performance metrics segmented by demographics and device types. Mixpo's services cater to a wide array of clients, including brand advertisers, local and national media sales, and advertising networks. As of 2017, Mixpo operates as a subsidiary of Netsertive, Inc.

Neuromed Pharmaceuticals is focused on the development, production, and marketing of pain therapies in Canada and the United States. Neuromed Pharmaceuticals was acquired by Zalicus in December 2009. Neuromed Pharmaceuticals was founded in 1998 and is based in Vancouver, Canada.

NxtPhase develops, manufactures, and markets optical sensor and digital solutions for the electric power industry. The company’s products include optical current and voltage sensors; and opto-electronic modules that provide signal processing electronics for voltage and current transducers. NxtPhase was founded in 1993 and is headquartered in Vancouver, Canada.

Neuromed Pharmaceuticals is focused on the development, production, and marketing of pain therapies in Canada and the United States. Neuromed Pharmaceuticals was acquired by Zalicus in December 2009. Neuromed Pharmaceuticals was founded in 1998 and is based in Vancouver, Canada.